经超声介导基因递送至内源性祖细胞的原位骨组织工程:迷你猪研究
研究在尤卡坦迷你猪胫骨建立临界尺寸骨折模型,植入胶原支架招募内源性间充质干/祖细胞,两周后经皮超声介导报告基因递送成功转染骨折部位40%细胞,其中80%表达MSC标志物。递送人BMP-6质粒DNA后,微CT与生物力学分析显示治疗6周时所有动物实现完全影像学与功能性骨折愈合,而对照动物为骨不连。
要点
- 超声介导报告基因递送转染骨折部位40%细胞,80%转染细胞表达MSC标志物。
- 超声介导BMP-6基因递送使所有动物在治疗后6周实现完全影像学与功能性愈合。
- 对照动物在治疗后6周仍为骨不连,提示该方法可治疗大型动物骨不连。
核心结论
- 超声介导基因递送至内源性间充质祖细胞可有效治疗大型动物的骨不连骨折,满足骨科未满足需求并为临床转化提供新可能。
研究设计与样本
- 在尤卡坦迷你猪胫骨手术建立临界尺寸骨折模型,置入胶原支架以促进内源性间充质干/祖细胞(MSCs)募集至骨折部位。
主要发现
- 两周后经皮超声介导报告基因递送成功转染骨折部位40%的细胞,流式细胞术显示80%的转染细胞表达MSC标志物。
- 超声递送人骨形态发生蛋白-6(BMP-6)质粒DNA导致BMP-6在骨折区域局部短暂表达和分泌。
- 微计算机断层扫描和生物力学分析显示,超声介导BMP-6基因递送使所有动物在治疗后6周实现完全影像学与功能性骨折愈合,而对照动物为骨不连。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
More than 2 million bone-grafting procedures are performed each year using autografts or allografts. However, both options carry disadvantages, and there remains a clear medical need for the development of new therapies for massive bone loss and fracture nonunions. We hypothesized that localized ultrasound-mediated, microbubble-enhanced therapeutic gene delivery to endogenous stem cells would induce efficient bone regeneration and fracture repair. To test this hypothesis, we surgically created a critical-sized bone fracture in the tibiae of Yucatán mini-pigs, a clinically relevant large animal model. A collagen scaffold was implanted in the fracture to facilitate recruitment of endogenous mesenchymal stem/progenitor cells (MSCs) into the fracture site. Two weeks later, transcutaneous ultrasound-mediated reporter gene delivery successfully transfected 40% of cells at the fracture site, and flow cytometry showed that 80% of the transfected cells expressed MSC markers. Human bone morphogenetic protein-6 (BMP-6) plasmid DNA was delivered using ultrasound in the same animal model, leading to transient expression and secretion of BMP-6 localized to the fracture area. Micro-computed tomography and biomechanical analyses showed that ultrasound-mediated BMP-6 gene delivery led to complete radiographic and functional fracture healing in all animals 6 weeks after treatment, whereas nonunion was evident in control animals. Collectively, these findings demonstrate that ultrasound-mediated gene delivery to endogenous mesenchymal progenitor cells can effectively treat nonhealing bone fractures in large animals, thereby addressing a major orthopedic unmet need and offering new possibilities for clinical translation.
引用
- Bez M, Sheyn D, Tawackoli W, et al. In situ bone tissue engineering via ultrasound-mediated gene delivery to endogenous progenitor cells in mini-pigs. Sci Transl Med. 2017. PMID: 28515335. doi:10.1126/scitranslmed.aal3128
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。